Just want to reiterate: the president is getting dexamethasone, which is not recommended for mild covid-19. As wrote in June, it "may be risky for patients with milder illness, and the timing of the treatment is critical.”
The president being prescribed dexamethasone is a significant indication of the severity of his case. Studies have shown that it isn't useful and is often harmful when used to treat mild Covid-19 cases
This earlier story on dexamethasone — its uses and its dangers — points to the severity of covid-19 in those who end up taking the drug. Conley said today that doctors gave it to a Trump.
Dexamethasone cut deaths in very sick #Covid19 patients -- but may be downright harmful to people with mild symptoms. Don't try it at home!
Scientists had reported the 1st drug to reduce deaths among critically ill #COVID19 patients: #dexamethasone. Now the full study is posted online. It shows the drug may be risky for patients with milder illness & the timing of the treatment is critical.
One aspect of that dexamethasone study that has been largely overlooked: Patients with mild Covid-19 did not benefit, and may have been a greater risk. 
One aspect of that dexamethasone study that has been largely overlooked: Patients with mild Covid-19 did not benefit, and may have been a greater risk. 
I have now had multiple people tell me this story is why we have to wait for papers, not go off press releases (& protocols & SAPs) I would humbly suggest: you did not actually read the press release.
Breakthrough drug #dexamethasone cut deaths in very sick #Covid19 patients but is harmful for those with mild cases, by via
Dexamethasone appears to help #COVID19 patients requiring oxygen or ventilation but may be risky for mild cases - The New York Times
1/n I am shocked — shocked! — to find doubts about the hype around #dexamethasone now being voiced in public, look, in real grown-ass newspapers, doubts voiced by real grown-ass medicos. Via (thanks!)
“Now the full study, neither peer reviewed nor published yet, has been posted online, and it holds a surprise.” Not surprisingly—only for severe cases and can harm those with mild cases
Breakthrough Drug for #COVID19, #Dexamethasone, May Be Risky for Mild Cases #RECOVERYtrial #coronavirus
2/n If you read this NYT (god forbid, I know, I know) report carefully, you will note it's stock bog-normal concerns, exactly the concerns any experienced (I know, rite) medico would have in using #dexamethasone too early in treatment for #COVID19.
#CCC19 #oncoalert Breakthrough Drug for Covid-19 May Be Risky for Mild Cases Dexamethasone seems to help very sick patients but risky for patients with milder illness: timing is critical
A reason why we should all wait for the full study report to be published in peer reviewed journals. Making conclusions from press releases in not a good idea => Breakthrough Drug for Covid-19 May Be Risky for Mild Cases - The New York Times